Adjunctive therapies and immunomodulating agents for severe influenza. (Q30355446)

20 June 2017

title

Adjunctive therapies and immunomodulating agents for severe influenza. (English)

1 reference

20 June 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

Nelson L. Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

author name string

David S C Hui

series ordinal

1

1 reference

20 June 2017

language of work or name

1 reference

1 November 2013

1 reference

Influenza and Other Respiratory Viruses

20 June 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

volume

7 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

page(s)

52-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

14 May 2020

cites work

1 reference

Re-emergence of fatal human influenza A subtype H5N1 disease

21 January 2018

1 reference

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

21 January 2018

1 reference

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

21 January 2018

1 reference

Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

21 January 2018

1 reference

Outcomes of adults hospitalised with severe influenza.

21 January 2018

1 reference

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

21 January 2018

1 reference

Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis

21 January 2018

1 reference

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

21 January 2018

1 reference

Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan

21 January 2018

1 reference

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

21 January 2018

1 reference

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

21 January 2018

1 reference

Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection

21 January 2018

1 reference

Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza

21 January 2018

1 reference

Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland

21 January 2018

1 reference

Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome

21 January 2018

1 reference

Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

21 January 2018

1 reference

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

21 January 2018

1 reference

Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome

21 January 2018

1 reference

Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids

21 January 2018

1 reference

Avascular necrosis of bone in severe acute respiratory syndrome

21 January 2018

1 reference

Invasive aspergillosis after pandemic (H1N1) 2009.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome

21 January 2018

1 reference

Oral prednisone therapy in experimental rhinovirus infections

21 January 2018

1 reference

Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.

21 January 2018

1 reference

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

21 January 2018

1 reference

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

21 January 2018

1 reference

Use of convalescent plasma therapy in SARS patients in Hong Kong

21 January 2018

1 reference

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

21 January 2018

1 reference

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

21 January 2018

1 reference

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.

21 January 2018

1 reference

High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia

21 January 2018

1 reference

N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV).

21 January 2018

1 reference

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.

21 January 2018

1 reference

Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations

21 January 2018

1 reference

A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.

21 January 2018

1 reference

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

21 January 2018

1 reference

Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

21 January 2018

1 reference

The effect of rosuvastatin in a murine model of influenza A infection

21 January 2018

1 reference

Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice

21 January 2018

1 reference

Influenza morbidity and mortality in elderly patients receiving statins: a cohort study.

21 January 2018

1 reference

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease

21 January 2018

1 reference

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

21 January 2018

1 reference

Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study

21 January 2018

1 reference

Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells

21 January 2018

1 reference

Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia.

21 January 2018

1 reference

Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection

21 January 2018

1 reference

Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

21 January 2018

1 reference

Azithromycin and the risk of cardiovascular death

21 January 2018

1 reference

Increased survival after gemfibrozil treatment of severe mouse influenza

21 January 2018

1 reference

Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection

21 January 2018

1 reference

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

21 January 2018

1 reference

Pioglitazone reduces monocyte activation in type 2 diabetes.

21 January 2018

1 reference

Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.

21 January 2018

1 reference

Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection.

21 January 2018

1 reference

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.

21 January 2018

1 reference

Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.

21 January 2018

1 reference

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

21 January 2018

1 reference

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

21 January 2018

1 reference

Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion

21 January 2018

1 reference

Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis

21 January 2018

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience

1 reference

12 December 2020

Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection

1 reference

12 December 2020

Treatment with convalescent plasma for influenza A (H5N1) infection

1 reference

12 December 2020

Dexamethasone in community-acquired pneumonia

1 reference

12 December 2020

Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010.

1 reference

12 December 2020

The common cold: effects of intranasal fluticasone propionate treatment

1 reference

12 December 2020

Identifiers

DOI

10.1111/IRV.12171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6492653&resulttype=core&format=json